A pilot study of antipsychotic prescribing decisions for acutely-Ill hospitalized patients
- 15 January 2011
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 35 (1) , 246-251
Abstract
No abstract availableKeywords
Funding Information
- Pfizer Inc
- Department of Veterans Affairs, Veterans Health Administration, Office of Research Development
This publication has 26 references indexed in Scilit:
- Metabolic Syndrome and the Risk of Coronary Heart Disease in 367 Patients Treated With Second-Generation Antipsychotic DrugsThe Journal of Clinical Psychiatry, 2006
- Medical Decision Making in Antipsychotic Drug Choice for SchizophreniaAmerican Journal of Psychiatry, 2004
- Consensus Statement: Consensus Development Conference on Antipsychotic Drugs and Obesity and DiabetesThe Journal of Clinical Psychiatry, 2004
- A Meta-analysis of the Efficacy of Second-Generation AntipsychoticsArchives of General Psychiatry, 2003
- Antipsychotic Prescribing Practices in Connecticut's Public Mental Health System: Rates of Changing Medications and Prescribing StylesSchizophrenia Bulletin, 2002
- The Schizophrenia PORT Pharmacological Treatment Recommendations: Conformance and Implications for Symptoms and Functional OutcomeSchizophrenia Bulletin, 2002
- Antipsychotic Prescribing PracticesSchizophrenia Bulletin, 2002
- Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysisBMJ, 2000
- Factors influencing GPs' decisions on the treatment of hypercholesterolaemic patientsScandinavian Journal of Primary Health Care, 2000
- An Experimental Study of the Clinical Judgment of General Physicians in Evaluating and Prescribing for DepressionThe British Journal of Psychiatry, 1981